A holistic approach to the patients/Families with inborn errors of metabolism

1Noyes J, Pritchard A, Rees S, Hastings R, Jones K, Mason H, et al. Bridging the gap: transition from children’s to adult palliative care: final Report. Bangor University, United Kingdom, Together for Short Lives. Bangor University, UK; 2014. 48 p. Available from: https://www.togetherforshortlives.org.uk/wp-content/uploads/2018/01/ExRes-Bridging-The-Gap.pdf Access Date 30. August 2020. Noyes J Pritchard A Rees S Hastings R Jones K Mason H et al Bridging the gap: transition from children’s to adult palliative care: final Report. Bangor University, United Kingdom, Together for Short Lives Bangor University, UK 2014 48 p. Available from https://www.togetherforshortlives.org.uk/wp-content/uploads/2018/01/ExRes-Bridging-The-Gap.pdf Access Date 30. August 2020Search in Google Scholar

2Saudubray JM, Sedel F, Walter JH. Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis. 2006;29(2-3):261-74. DOI:10.1007/s10545-006-0358-0. Saudubray JM Sedel F Walter JH Clinical approach to treatable inborn metabolic diseases: an introduction J Inherit Metab Dis 2006292-3261 74 10.1007/s10545-006-0358-016763886Open DOISearch in Google Scholar

3Garbade SF, Shen N, Himmelreich N, Haas D, Trefz FK, Hoff-mann GF, et al. Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria. Genet Med. 2019;21(3):580-90. DOI:10.1038/s41436-018-0081-x. Garbade SF Shen N Himmelreich N Haas D Trefz FK Hoff-mann GF et al Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria Genet Med 2019213580 90 10.1038/s41436-018-0081-x29997390Open DOISearch in Google Scholar

4Boulding KE. General systems theory—the skeleton of science. Manage Sci. 1956;2(3):197-208. doi:10.1287/mnsc.2.3.197. Boulding KE General systems theory—the skeleton of science Manage Sci 195623197 208 10.1287/mnsc.2.3.197Open DOISearch in Google Scholar

5Von Bertalanfy L. The theory of open systems in physics and biology. Science. 1950;111(2872):23–9. doi:10.1126/sci-ence.111.2872.23. Von Bertalanfy L The theory of open systems in physics and biology Science 1950111287223–9 10.1126/sci-ence.111.2872.23Open DOISearch in Google Scholar

6Ten Hoedt AE, Hollak CE, Boelen CC, van der Herberg-van de Wetering NA, Ter Horst NM, Jonkers CF, et al. “MY PKU”: increasing self-management in patients with phenylketonuria. A randomized controlled trial. Orphanet J Rare Dis. 2011;6:48. doi:10.1186/1750-1172-6-48. Ten Hoedt AE Hollak CE Boelen CC van der Herberg-van de Wetering NA Ter Horst NM Jonkers CF et al “MY PKU”: increasing self-management in patients with phenylketonuria A randomized controlled trial. Orphanet J Rare Dis 2011648 10.1186/1750-1172-6-48313353621708003Open DOISearch in Google Scholar

7Mazur A, Dembinski L, Schrier L, Hadjipanayis A, Michaud PA. European Academy of Paediatric consensus statement on successful transition from paediatric to adult care for adolescents with chronic conditions. Acta Paediatr. 2017;106(8):1354–7. doi:10.1111/apa.13901. Mazur A Dembinski L Schrier L Hadjipanayis A Michaud PA European Academy of Paediatric consensus statement on successful transition from paediatric to adult care for adolescents with chronic conditions Acta Paediatr 201710681354 7 10.1111/apa.1390128471516Open DOISearch in Google Scholar

8Ewing CI, Cropper SA, Horsburgh TB. Developing, implementing and evaluating integrated care models for infants, children, young people and their families. Arch Dis Child. 2016;101(9):781–2. doi:10.1136/archdischild-2015-309886. Ewing CI Cropper SA Horsburgh TB Developing, implementing and evaluating integrated care models for infants, children, young people and their families Arch Dis Child 20161019781 2 10.1136/archdischild-2015-30988627484969Open DOISearch in Google Scholar

9Watson M. The importance of engaging users and measuring outcome for integrated care: response to Ewing and Woodman. Arch Dis Child. 2017;102(9):876–7. doi:10.1136/archdis-child-2017-313110. Watson M The importance of engaging users and measuring outcome for integrated care: response to Ewing and Woodman Arch Dis Child 20171029876 7 10.1136/archdis-child-2017-313110Open DOISearch in Google Scholar

10Wolfe I, Lemer C, Cass H. Integrated care: a solution for improving children’s health? Arch Dis Child. 2016;101(11):992–7. doi:10.1136/archdischild-2013-304442. Wolfe I Lemer C Cass H Integrated care: a solution for improving children’s health? Arch Dis Child 201610111992 7 10.1136/archdischild-2013-30444227052949Open DOISearch in Google Scholar

11Woodman J, Lewis H, Cheung R, Gilbert R, Wijlaars LP. Integrating primary and secondary care for children and young people: sharing practice. Arch Dis Child. 2016;101(9):792–7. doi:10.1136/archdischild-2015-308558. Woodman J Lewis H Cheung R Gilbert R Wijlaars LP Integrating primary and secondary care for children and young people: sharing practice Arch Dis Child 20161019792 7 10.1136/archdischild-2015-30855826487706Open DOISearch in Google Scholar

12Bali A, Hargreaves DS, Cowman J, Lakhanpaul M, Dunkley C, Power M, et al. Integrated care for childhood epilepsy: ongoing challenges and lessons for other long-term conditions. Arch Dis Child. 2016;101(11):1057–62. doi:10.1136/archdis-child-2015-309794. Bali A Hargreaves DS Cowman J Lakhanpaul M Dunkley C Power M et al Integrated care for childhood epilepsy: ongoing challenges and lessons for other long-term conditions Arch Dis Child 2016101111057 62 10.1136/archdis-child-2015-309794Open DOISearch in Google Scholar

13Ferreira CR, van Karnebeek CDM, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2019;21(1):102–6. doi:10.1038/s41436-018-0022-8. Ferreira CR van Karnebeek CDM Vockley J Blau N A proposed nosology of inborn errors of metabolism Genet Med 2019211102 6 10.1038/s41436-018-0022-8628670929884839Open DOISearch in Google Scholar

14Cederbaum JA, LeMons C, Rosen M, Ahrens M, Vonachen S, Cederbaum SD. Psychosocial issues and coping strategies in families affected by urea cycle disorders. J Pediatr. 2001;138(1 Suppl):S72–80. doi:10.1067/mpd.2001.111839. Cederbaum JA LeMons C Rosen M Ahrens M Vonachen S Cederbaum SD Psychosocial issues and coping strategies in families affected by urea cycle disorders J Pediatr 20011381 SupplS72 80 10.1067/mpd.2001.11183911148552Open DOISearch in Google Scholar

15Forsyth RJ. We have to talk about health-related quality of life. Arch Dis Child. 2018;103(10):913–4. doi:10.1136/archdis-child-2018-314951. Forsyth RJ We have to talk about health-related quality of life Arch Dis Child 201810310913 4 10.1136/archdis-child-2018-314951Open DOISearch in Google Scholar

16Bronfenbrenner U, Morris PA. The ecology of developmental processes. p. 993-1028. In: Damon W (editor in chief), Lerner RM (volume editor). Handbook of child psychology. Vol. 1: Theoretical models of human development. 5th ed. Chichester, UK: John Wiley & Sons Inc., 1998; 1274 p. ISBN 9780471055273. Bronfenbrenner U Morris PA The ecology of developmental processes. p. 993-1028. In: Damon W (editor in chief), Lerner RM (volume editor). Handbook of child psychology. Vol. 1: Theoretical models of human development. 5th ed Chichester, UK John Wiley & Sons Inc 1998 1274 p. ISBN 9780471055273Search in Google Scholar

17Bronfenbrenner U, Morris PA. The bioecological model of human development. p. 793–828. In: Damon W (editor in chief), Lerner RM (volume editor). Handbook of child psychology. Vol. 1: Theoretical models of human development. 6th ed. New York (NY), USA: John Wiley & Sons Inc.; 2006; XX, 1250 p. ISBN 9780471272878. Bronfenbrenner U Morris PA The bioecological model of human development. p. 793–828. In: Damon W (editor in chief), Lerner RM (volume editor). Handbook of child psychology. Vol. 1: Theoretical models of human development. 6th ed New York (NY), USA John Wiley & Sons Inc 2006 XX, 1250 p. ISBN 9780471272878Search in Google Scholar

18Siegler R, DeLoache J, Eisenberg N. How children develop. 4th ed. New York (NY), USA: Worth Publishing Ltd.; 2014. 666 pp. ISBN 978-1429242318. Siegler R DeLoache J Eisenberg N How children develop. 4th ed New York (NY), USA Worth Publishing Ltd 2014 666 pp. ISBN 978-142924231810.1007/978-1-319-17494-1Search in Google Scholar

19Grasemann C, Matar N, Bauer J, Manka E, Mundlos C, Krude H, et al. Ein strukturierter Versorgungs-pfad von der Pädiatrie in die Erwachsenenmedizin für Jugend-liche und junge Erwachsene mit einer seltenen Erkrankung. Monatsschr Kinderheilkd. 2020 May 25 Epub ahead of print. doi:10.1007/s00112-020-00929-5. Grasemann C Matar N Bauer J Manka E Mundlos C Krude H et al Ein strukturierter Versorgungs-pfad von der Pädiatrie in die Erwachsenenmedizin für Jugend-liche und junge Erwachsene mit einer seltenen Erkrankung Monatsschr Kinderheilkd 2020 May 25 Epub ahead of print 10.1007/s00112-020-00929-5Open DOISearch in Google Scholar

20Gramer G, Haege G, Glahn EM, Hoffmann GF, Lindner M, Burgard P. Living with an inborn error of metabolism detected by newborn screening-parents’ perspectives on child development and impact on family life. J Inherit Metab Dis. 2014;37(2):189-95. DOI:10.1007/s10545-013-9639-6. Gramer G Haege G Glahn EM Hoffmann GF Lindner M Burgard P Living with an inborn error of metabolism detected by newborn screening-parents’ perspectives on child development and impact on family life J Inherit Metab Dis 2014372189 95 10.1007/s10545-013-9639-623949009Open DOISearch in Google Scholar

21Weber SL, Segal S, Packman W. Inborn errors of metabolism: psychosocial challenges and proposed family systems model of intervention. Mol Genet Metab. 2012;105(4):537–41. doi:10.1016/j.ymgme.2012.01.014. Weber SL Segal S Packman W Inborn errors of metabolism: psychosocial challenges and proposed family systems model of intervention Mol Genet Metab 20121054537 41 10.1016/j.ymgme.2012.01.01422532988Open DOISearch in Google Scholar

22Besier T, Hölling H, Schlack R, West C, Goldbeck L. Impact of a family-oriented rehabilitation programme on behavioural and emotional problems in healthy siblings of chronically ill children. Child Care Health Dev. 2010;36(5):686-95. DOI:10.1111/j.1365-2214.2010.01085.x. Besier T Hölling H Schlack R West C Goldbeck L Impact of a family-oriented rehabilitation programme on behavioural and emotional problems in healthy siblings of chronically ill children Child Care Health Dev 2010365686 95 10.1111/j.1365-2214.2010.01085.x20345396Open DOISearch in Google Scholar

23Hagedorn TS, van Berkel P, Hammerschmidt G, Lhotáková M, Saludes RP. Requirements for a minimum standard of care for phenylketonuria: the patients’ perspective. Orphanet J Rare Dis. 2013;8:191. doi:10.1186/1750-1172-8-191. Hagedorn TS van Berkel P Hammerschmidt G Lhotáková M Saludes RP Requirements for a minimum standard of care for phenylketonuria: the patients’ perspective Orphanet J Rare Dis 20138191 10.1186/1750-1172-8-191387857424341788Open DOISearch in Google Scholar

24Evans I, Thornton H, Chalmers I, Glasziou P. Testing treatments: better research for better healthcare. 2nd ed. London (UK): Pinter & Martin; 2011. 199 pp. ISBN 978-1-905177-48-6. Evans I Thornton H Chalmers I Glasziou P Testing treatments: better research for better healthcare. 2nd ed London (UK) Pinter & Martin; 2011 199 pp. ISBN 978-1-905177-48-6Search in Google Scholar

25Boy N, Mühlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, et al.; Additional individual contributors. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40(1):75–101. doi:10.1007/s10545-016-9999-9. Boy N Mühlhausen C Maier EM Heringer J Assmann B Burgard P et al Additional individual contributors. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision J Inherit Metab Dis 201740175 101 10.1007/s10545-016-9999-9Open DOISearch in Google Scholar

26Burgard P, Ullrich K, Ballhausen D, Hennermann JB, Hollak CEM, Langeveld M, et al. Issues with European guidelines for phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):681–3. doi:10.1016/S2213-8587(17)30201-2. Burgard P Ullrich K Ballhausen D Hennermann JB Hollak CEM Langeveld M et al Issues with European guidelines for phenylketonuria Lancet Diabetes Endocrinol 201759681 3 10.1016/S2213-8587(17)30201-2Open DOISearch in Google Scholar

27Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. doi:10.1186/1750-1172-7-32. Häberle J Boddaert N Burlina A Chakrapani A Dixon M Huemer M et al Suggested guidelines for the diagnosis and management of urea cycle disorders Orphanet J Rare Dis 2012732 10.1186/1750-1172-7-32Open DOISearch in Google Scholar

28van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–56. doi:10.1016/S2213-8587(16)30320-5.. van Spronsen FJ van Wegberg AM Ahring K Bélanger-Quintana A Blau N Bosch AM et al Key European guidelines for the diagnosis and management of patients with phenylketonuria Lancet Diabetes Endocrinol 201759743 56 10.1016/S2213-8587(16)30320-5Open DOISearch in Google Scholar

29Heringer J, Boy SP, Ensenauer R, Assmann B, Zschocke J, Harting I, et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol. 2010;68(5):743–52. doi:10.1002/ana.22095. Heringer J Boy SP Ensenauer R Assmann B Zschocke J Harting I et al Use of guidelines improves the neurological outcome in glutaric aciduria type I Ann Neurol 2010685743 52 10.1002/ana.22095Open DOISearch in Google Scholar

30Burgard P. Structured communication and behavioural medicine. p. 33–40. In: Hoffmann GF, Zschocke J, Nyhan WL, editors. Inherited metabolic diseases: a clinical approach. 2nd ed. Berlin, Heidelberg: Springer; 2017; XVII, 605 pp. ISBN 978-3-66249408-0. e-ISSN 978-3-662-49410-3. doi:10.1007/978-3-662-49410-3. Burgard P Structured communication and behavioural medicine. p. 33–40 Hoffmann GF Zschocke J Nyhan WL editors. Inherited metabolic diseases: a clinical approach. 2nd ed Berlin, Heidelberg Springer 2017 XVII, 605 pp. ISBN 978-3-66249408-0. e-ISSN 978-3-662-49410-3 10.1007/978-3-662-49410-3Open DOISearch in Google Scholar

31Pfeil J, Listl S, Hoffmann GF, Kölker S, Lindner M, Burgard P. Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis. 2013;8:167. doi:10.1186/1750-1172-8-167. Pfeil J Listl S Hoffmann GF Kölker S Lindner M Burgard P Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis Orphanet J Rare Dis 20138167 10.1186/1750-1172-8-167Open DOISearch in Google Scholar

32Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371(9629):2039–41. doi:10.1016/S0140-6736(08)60872-7. Schieppati A Henter JI Daina E Aperia A Why rare diseases are an important medical and social issue Lancet 200837196292039 41 10.1016/S0140-6736(08)60872-7Open DOISearch in Google Scholar

33Abraham J. The pharmaceutical industry as a political player. Lancet. 2002;360(9344):1498–502. doi:10.1016/S0140-6736(02)11477-2. Abraham J The pharmaceutical industry as a political player Lancet 200236093441498 502 10.1016/S0140-6736(02)11477-2Open DOISearch in Google Scholar

34Collier J, Iheanacho I. The pharmaceutical industry as an informant. Lancet. 2002;360(9343):1405–9. doi:10.1016/S0140-6736(02)11394-8. Collier J Iheanacho I The pharmaceutical industry as an informant Lancet 200236093431405 9 10.1016/S0140-6736(02)11394-8Open DOISearch in Google Scholar

35Henry D, Lexchin J. The pharmaceutical industry as a medicines provider. Lancet. 2002;360(9345):1590–5. doi:10.1016/S0140-6736(02)11527-3. Henry D Lexchin J The pharmaceutical industry as a medicines provider Lancet 200236093451590 5 10.1016/S0140-6736(02)11527-3Open DOISearch in Google Scholar

36Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002;360(9346):1682–1684. doi:10.1016/S0140-6736(02)11599-6. Dukes MN Accountability of the pharmaceutical industry Lancet 200236093461682 1684 10.1016/S0140-6736(02)11599-6Open DOISearch in Google Scholar

37Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. doi:10.1186/s13023-014-0130-8. Baumgartner MR Hörster F Dionisi-Vici C Haliloglu G Karall D Chapman KA et al Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia Orphanet J Rare Dis 20149130 10.1186/s13023-014-0130-8Open DOISearch in Google Scholar

38Norris SL, Nichols PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl):15–38. doi:10.1016/s0749-3797(02)00423-3. Norris SL Nichols PJ Caspersen CJ Glasgow RE Engelgau MM Jack L et al The effectiveness of disease and case management for people with diabetes A systematic review. Am J Prev Med 2002224 Suppl15 38 10.1016/s0749-3797(02)00423-3Open DOISearch in Google Scholar

39Héon-Klin V. European Reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12(1):137. doi:10.1186/s13023-017-0676-3. Héon-Klin V European Reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis 2017121137 10.1186/s13023-017-0676-3554747128784158Open DOISearch in Google Scholar